Shenzhen Bioeasy Biotechnology Co Ltd
300942
Company Profile
Business description
Shenzhen Bioeasy Biotechnology Co Ltd focuses on the research, development, production, sales, and related services of precise and rapid food safety testing products, and is expanding into the field of point-of-care testing (POCT) for in vitro diagnostics.
Contact
No. 289 Yunchang Road, Hangcheng Street
Room A101, Building 2, Yirui Bio-industry Park
Sanwei Community, Bao'an District
Guangdong Province
Shenzhen518126
CHNT: +86 75523095742
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
542
Stocks News & Analysis
stocks
Cheap ASX share may have more room to run
Shares are cheap despite rebounding share price, yet risks remain.
stocks
ASX listed media giant drives strong earnings growth
Digital growth drives earnings beat for media share.
stocks
ASX real estate platform outperforms yet questions remain
Valuation remains a key concern despite strong August reporting.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,424.10 | 13.30 | -0.14% |
| CAC 40 | 8,719.82 | 4.89 | 0.06% |
| DAX 40 | 26,431.06 | 111.61 | 0.42% |
| Dow JONES (US) | 54,036.93 | 151.83 | 0.28% |
| FTSE 100 | 10,876.04 | 25.05 | -0.23% |
| HKSE | 25,937.49 | 269.46 | 1.05% |
| NASDAQ | 26,690.62 | 342.26 | 1.30% |
| Nikkei 225 | 66,970.22 | 1,363.51 | 2.08% |
| NZX 50 Index | 13,888.24 | 64.11 | 0.46% |
| S&P 500 | 7,757.64 | 47.68 | 0.62% |
| S&P/ASX 200 | 9,232.60 | 17.00 | -0.18% |
| SSE Composite Index | 3,966.59 | 26.56 | 0.67% |